1. 93 Targeting sirt2 rescues the metabolic fitness and effector functions of tumor-reactive T cells within the metabolically restricted tumor microenvironment. (9th November 2020) Authors: Hamaidi, Imene; Zhang, Lin; Kim, Nayoung; Wang, Min-Hsuan; Iclozan, Cristina; Fang, Bin; Liu, Min; Koomen, John; Berglund, Anders; Yoder, Sean; Yao, Jiqiang; Engelman, Robert; Creelan, Ben; Conejo-Garcia, Jose; Antonia, Scott; Mule, James; Kim, Sungjune Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An FGFR3/MYC positive feedback loop provides new opportunities for targeted therapies in bladder cancers. Issue 4 (20th February 2018) Authors: Mahe, Mélanie; Dufour, Florent; Neyret‐Kahn, Hélène; Moreno‐Vega, Aura; Beraud, Claire; Shi, Mingjun; Hamaidi, Imene; Sanchez‐Quiles, Virginia; Krucker, Clementine; Dorland‐Galliot, Marion; Chapeaublanc, Elodie; Nicolle, Remy; Lang, Hervé; Pouponnot, Celio; Massfelder, Thierry; Radvanyi, François... Journal: EMBO molecular medicine Issue: Volume 10:Issue 4(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial. Issue 10357 (24th September 2022) Authors: Kim, Sungjune; Wuthrick, Evan; Blakaj, Dukagjin; Eroglu, Zeynep; Verschraegen, Claire; Thapa, Ram; Mills, Matthew; Dibs, Khaled; Liveringhouse, Casey; Russell, Jeffery; Caudell, Jimmy J; Tarhini, Ahmad; Markowitz, Joseph; Kendra, Kari; Wu, Richard; Chen, Dung-Tsa; Berglund, Anders; Michael, Laure... Journal: Lancet Issue: Volume 400:Issue 10357(2022) Page Start: 1008 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗